Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide.
暂无分享,去创建一个
[1] G. Glazner,et al. Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor. , 1997, The Journal of clinical investigation.
[2] A. Arimura,et al. Ontogeny of pituitary adenylate cyclase activating polypeptide and its receptor mRNA in the mouse brain , 1996, Regulatory Peptides.
[3] M. Delgado,et al. Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA , 1996, Journal of Neuroimmunology.
[4] P. Nelson,et al. Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin I. , 1996, Journal of neurobiology.
[5] J. Boonstra,et al. Parathyroid hormone related peptide mRNA expression during murine postimplantation development: evidence for involvement in multiple differentiation processes. , 1996, The International journal of developmental biology.
[6] I. Gozes,et al. A femtomolar-acting neuroprotective peptide. , 1996, The Journal of clinical investigation.
[7] D. Pozo,et al. Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages , 1996, Regulatory Peptides.
[8] J. Ellison,et al. Embryonic Expression of Vasoactive Intestinal Peptide (VIP) and VIP Receptor Genes , 1996, Journal of neurochemistry.
[9] G. Glazner,et al. Interleukin-1 alpha and vasoactive interstinal peptide: Enigmatic regulation of neuronal survival , 1995, International Journal of Developmental Neuroscience.
[10] I. Gozes,et al. Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. , 1995, The Journal of pharmacology and experimental therapeutics.
[11] Z. Werb,et al. Implantation and the placenta: key pieces of the development puzzle. , 1994, Science.
[12] P. Gressens,et al. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse. , 1994, The Journal of clinical investigation.
[13] S. Landis,et al. The appearance of NPY and VIP in sympathetic neuroblasts and subsequent alterations in their expression , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[14] M. Sporn,et al. Maternal rescue of transforming growth factor-beta 1 null mice. , 1994, Science.
[15] P. Gressens,et al. Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: Relation to ontogenic events , 1994, The Journal of comparative neurology.
[16] M. Delgado,et al. Vasoactive intestinal peptide (VIP) mRNA expression in rat T and B lymphocytes , 1994, Regulatory Peptides.
[17] L. Mincheva-Nilsson,et al. Immunomorphologic studies of human decidua-associated lymphoid cells in normal early pregnancy. , 1994, Journal of immunology.
[18] G. Fink,et al. The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide , 1993, FEBS letters.
[19] P. Gressens,et al. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos , 1993, Nature.
[20] S. Carding,et al. Characterization of gamma delta T lymphocytes at the maternal-fetal interface. , 1992, Journal of immunology.
[21] J. Hill,et al. Regional distribution of guanine nucleotide-sensitive and guanine nucleotide-insensitive vasoactive intestinal peptide receptors in rat brain , 1992, Neuroscience.
[22] R. Shigemoto,et al. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide , 1992, Neuron.
[23] E. Goetzl,et al. Cloning and expression of the human vasoactive intestinal peptide receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[24] T. Görcs,et al. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. , 1991, Endocrinology.
[25] I. Black,et al. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts , 1990, Nature.
[26] G. Westbrook,et al. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide , 1987, The Journal of cell biology.
[27] J. Bulmer,et al. Immunohistological characterization of lymphoid cell populations in the early human placental bed. , 1984, Immunology.
[28] J. Altman,et al. The development of the rat spinal cord. , 1984, Advances in anatomy, embryology, and cell biology.
[29] J. Larsen,et al. Vasoactive intestinal polypeptide and the female genital tract: relationship to reproductive phase and delivery. , 1982, American journal of obstetrics and gynecology.
[30] G. Glazner,et al. Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent. , 1996, The Journal of clinical investigation.
[31] T. Moody,et al. Effects of guanine nucleotides on CNS neuropeptide receptors. , 1981, Journal of supramolecular structure and cellular biochemistry.